Ulcerative colitis: diagnosis and management
Authors:
Abstract
What is it, and who gets it? Ulcerative colitis is a form of inflammatory bowel disease characterised by diffuse inflammation of the colonic mucosa. It affects the rectum and extends proximally along a variable length of the colon. The disease can be categorised as left sided colitis (inflammation up to the splenic flexure) or extensive colitis (inflammation beyond the splenic flexure). These categories are useful when formulating treatment options and planning the timing of surveillance colonoscopy, which is used to detect and prevent colorectal carcinoma. Colitis affects about one in 1000 people in the Western world.Keywords
This publication has 22 references indexed in Scilit:
- Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease2006
- The Changing Face of Colorectal Cancer in Inflammatory Bowel Disease: Progress at Last!Gastroenterology, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Systematic review: is ingestion of paracetamol or non‐steroidal anti‐inflammatory drugs associated with exacerbations of inflammatory bowel disease?Alimentary Pharmacology & Therapeutics, 2004
- Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineGut, 2004
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2004
- Management of inflammatory bowel disease2004
- Ciclosporin and refractory colitisEuropean Journal of Gastroenterology & Hepatology, 2003
- Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.Gut, 1993
- Cortisone in Ulcerative ColitisBMJ, 1955